Regulation of cutaneous malignancy by gammadelta T cells
- PMID: 11567106
- DOI: 10.1126/science.1063916
Regulation of cutaneous malignancy by gammadelta T cells
Abstract
The localization of gammadelta T cells within epithelia suggests that these cells may contribute to the down-regulation of epithelial malignancies. We report that mice lacking gammadelta cells are highly susceptible to multiple regimens of cutaneous carcinogenesis. After exposure to carcinogens, skin cells expressed Rae-1 and H60, major histocompatibility complex-related molecules structurally resembling human MICA. Each of these is a ligand for NKG2d, a receptor expressed by cytolytic T cells and natural killer (NK) cells. In vitro, skin-associated NKG2d+ gammadelta cells killed skin carcinoma cells by a mechanism that was sensitive to blocking NKG2d engagement. Thus, local T cells may use evolutionarily conserved proteins to negatively regulate malignancy.
Comment in
-
Immunology. Stress, NK receptors, and immune surveillance.Science. 2001 Oct 19;294(5542):534-6. doi: 10.1126/science.1066284. Epub 2001 Sep 20. Science. 2001. PMID: 11567108 No abstract available.
Similar articles
-
Immunology. Stress, NK receptors, and immune surveillance.Science. 2001 Oct 19;294(5542):534-6. doi: 10.1126/science.1066284. Epub 2001 Sep 20. Science. 2001. PMID: 11567108 No abstract available.
-
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.Eur J Immunol. 2003 Feb;33(2):381-91. doi: 10.1002/immu.200310012. Eur J Immunol. 2003. PMID: 12645935
-
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.Scand J Immunol. 2007 Aug-Sep;66(2-3):320-8. doi: 10.1111/j.1365-3083.2007.01963.x. Scand J Immunol. 2007. PMID: 17635809
-
NKG2D and Related Immunoreceptors.Adv Protein Chem. 2004;68:281-312. doi: 10.1016/S0065-3233(04)68008-9. Adv Protein Chem. 2004. PMID: 15500864 Review.
-
Distinct pattern of human Vdelta1 gammadelta T cells recognizing MICA.Cell Mol Immunol. 2005 Aug;2(4):253-8. Cell Mol Immunol. 2005. PMID: 16274622 Review.
Cited by
-
In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study.Medicine (Baltimore). 2016 Sep;95(39):e4909. doi: 10.1097/MD.0000000000004909. Medicine (Baltimore). 2016. PMID: 27684826 Free PMC article. Clinical Trial.
-
Naturally Occurring Genetic Alterations in Proximal TCR Signaling and Implications for Cancer Immunotherapy.Front Immunol. 2021 May 3;12:658611. doi: 10.3389/fimmu.2021.658611. eCollection 2021. Front Immunol. 2021. PMID: 34012443 Free PMC article. Review.
-
Immune selective pressure and HLA class I antigen defects in malignant lesions.Cancer Immunol Immunother. 2007 Feb;56(2):227-36. doi: 10.1007/s00262-006-0183-1. Epub 2006 Jun 17. Cancer Immunol Immunother. 2007. PMID: 16783578 Free PMC article. Review.
-
The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors.J Clin Invest. 2007 Jul;117(7):1884-92. doi: 10.1172/JCI30068. J Clin Invest. 2007. PMID: 17607362 Free PMC article.
-
The contribution of Langerhans cells to cutaneous malignancy.Trends Immunol. 2010 Dec;31(12):460-6. doi: 10.1016/j.it.2010.10.001. Epub 2010 Nov 9. Trends Immunol. 2010. PMID: 21071271 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases